ASH 2018 Caudia Stege HOVON 123

Caudia Stege PhD student, Amsterdam UMC, Amsterdam 

 

Geriatric Impairments and Low Muscle Mass Are Associated with Treatment Discontinuation and Overall Survival in Newly Diagnosed Non-Transplant Eligible Multiple Myeloma Patients (nte-NDMM) Treated with Dose-Adjusted Melphalan-Prednisone-Bortezomib (MPV) – Results of the Dutch HOVON 123 Study

 

https://ash.confex.com/ash/2018/webprogram/Paper116920.html

 

0119HEM1092342
×

Ask Speakers

×

Medical Information Request